Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Aug 25:1:24.
doi: 10.3389/fmed.2014.00024. eCollection 2014.

Intestinal epithelium in inflammatory bowel disease

Affiliations
Review

Intestinal epithelium in inflammatory bowel disease

Mehmet Coskun. Front Med (Lausanne). .

Abstract

The intestinal epithelium has a strategic position as a protective physical barrier to luminal microbiota and actively contributes to the mucosal immune system. This barrier is mainly formed by a monolayer of specialized intestinal epithelial cells (IECs) that are crucial in maintaining intestinal homeostasis. Therefore, dysregulation within the epithelial layer can increase intestinal permeability, lead to abnormalities in interactions between IECs and immune cells in underlying lamina propria, and disturb the intestinal immune homeostasis, all of which are linked to the clinical disease course of inflammatory bowel disease (IBD). Understanding the role of the intestinal epithelium in IBD pathogenesis might contribute to an improved knowledge of the inflammatory processes and the identification of potential therapeutic targets.

Keywords: Crohn’s disease; barrier dysfunction; inflammatory bowel disease; intestinal epithelium; tight junctions; ulcerative colitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Genetics, gut microbiota, and an uncontrolled immune response cause defects in epithelial barrier function by affecting the barrier integrity, increasing tissue destruction and mucosal inflammation.

References

    1. Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet (2012) 380:1606–19.10.1016/S0140-6736(12)60150-0 - DOI - PubMed
    1. Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet (2012) 380:1590–605.10.1016/S0140-6736(12)60026-9 - DOI - PubMed
    1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol (2010) 28:573–621.10.1146/annurev-immunol-030409-101225 - DOI - PMC - PubMed
    1. Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol (2006) 3:390–407.10.1038/ncpgasthep0528 - DOI - PubMed
    1. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet (2010) 42:1118–25.10.1038/ng.717 - DOI - PMC - PubMed